These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19663677)

  • 1. Pharmacogenetics of testosterone replacement therapy.
    Zitzmann M
    Pharmacogenomics; 2009 Aug; 10(8):1341-9. PubMed ID: 19663677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men.
    Zitzmann M
    Nat Clin Pract Urol; 2007 Mar; 4(3):161-6. PubMed ID: 17347661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the CAG repeat androgen receptor polymorphism in andrology.
    Zitzmann M
    Front Horm Res; 2009; 37():52-61. PubMed ID: 19011288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.
    Zitzmann M; Nieschlag E
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3844-53. PubMed ID: 17635942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study.
    Zitzmann M; Depenbusch M; Gromoll J; Nieschlag E
    J Clin Endocrinol Metab; 2003 May; 88(5):2049-54. PubMed ID: 12727953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of testosterone replacement and its pharmacogenetics on physical performance and metabolism.
    Zitzmann M
    Asian J Androl; 2008 May; 10(3):364-72. PubMed ID: 18385898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAG repeat testing of androgen receptor polymorphism: is this necessary for the best clinical management of hypogonadism?
    Francomano D; Greco EA; Lenzi A; Aversa A
    J Sex Med; 2013 Oct; 10(10):2373-81. PubMed ID: 23844628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
    Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
    J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central body fat changes in men affected by post-surgical hypogonadotropic hypogonadism undergoing testosterone replacement therapy are modulated by androgen receptor CAG polymorphism.
    Tirabassi G; delli Muti N; Buldreghini E; Lenzi A; Balercia G
    Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):908-13. PubMed ID: 24787905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism.
    Tirabassi G; delli Muti N; Gioia A; Biagioli A; Lenzi A; Balercia G
    J Endocrinol Invest; 2014 Apr; 37(4):393-400. PubMed ID: 24458833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study.
    Stanworth RD; Akhtar S; Channer KS; Jones TH
    Eur J Endocrinol; 2014 Feb; 170(2):193-200. PubMed ID: 24165020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of pilosebaceous unit responsiveness to testosterone therapy in patients with hypogonadotrophic hypogonadism.
    Dhiman P; Bhansali A; Prasad R; Dutta P; Walia R; Ravikiran M
    Andrologia; 2011 Dec; 43(6):422-7. PubMed ID: 21486418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
    Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
    J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute endothelial response to testosterone gel administration in men with severe hypogonadism and its relationship to androgen receptor polymorphism: a pilot study.
    Francomano D; Fattorini G; Gianfrilli D; Paoli D; Sgrò P; Radicioni A; Romanelli F; Di Luigi L; Gandini L; Lenzi A; Aversa A
    J Endocrinol Invest; 2016 Mar; 39(3):265-71. PubMed ID: 26162521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients.
    Zitzmann M; Depenbusch M; Gromoll J; Nieschlag E
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6208-17. PubMed ID: 15579779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging males' symptoms in relation to the genetically determined androgen receptor CAG polymorphism, sex hormone levels and sample membership.
    Schneider G; Nienhaus K; Gromoll J; Heuft G; Nieschlag E; Zitzmann M
    Psychoneuroendocrinology; 2010 May; 35(4):578-87. PubMed ID: 19804943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of gonadotropin administration for spermatogenesis induction in hypogonadotropic hypogonadism: a possible role of androgen receptor CAG repeat polymorphism and therapeutic measures.
    Giagulli VA; Triggiani V; Corona G; Carbone MD; Tafaro E; Licchelli B; Resta F; Sabbà C; Maggi M; Guastamacchia E
    Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):236-42. PubMed ID: 22385118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism.
    Crabbe P; Bogaert V; De Bacquer D; Goemaere S; Zmierczak H; Kaufman JM
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3604-10. PubMed ID: 17579205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism.
    Giagulli VA; Triggiani V; Carbone MD; Corona G; Tafaro E; Licchelli B; Guastamacchia E
    J Sex Med; 2011 Dec; 8(12):3471-8. PubMed ID: 21995803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymorphism of AR gene CAG copy number and late-onset hypogonadism in males].
    Liang GQ; Wu M; Wang B; Liu ZY; Yao WL; Li Z; Sun YH
    Zhonghua Nan Ke Xue; 2012 Sep; 18(9):797-802. PubMed ID: 23193666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.